KR102279779B1 - Specific primer set for detecting Alstroemeria mosaic virus and uses thereof - Google Patents

Abstract

The present invention relates to a primer set for specific detection of Alstroemeria mosaic virus (AlMV) and uses thereof, and since five primer sets of the present invention can specifically detect the AlMV, it is considered that the introduction of the AlMV into Korea can be effectively prevented.

Description

A primer set for specifically detecting Alstroemeria mosaic virus and its use {Specific primer set for detecting Alstroemeria mosaic virus and uses thereof}

The present invention relates to a primer set for specifically detecting Alstroemeria mosaic virus and to a use thereof.

Virus damage is spreading as the ecosystem changes due to climate change, the evolution and mutation of plants and viruses, and the number of virus vectors increase. In addition, the recent increase in international trade and imports and exports of various plants is increasing the possibility of introducing new plant viruses into the country.

Since 2000, several countries, including the United States, Australia, and China, have strengthened plant quarantine. This is because the cost to prevent the invasion of new pests is much more economical compared to the total cost of damage and control costs caused by the invasion of new pests.

Currently, in the detection of RNA viruses, the RT-PCR method with high detection sensitivity and convenience is most commonly used, and the development of species-specific primers is the most important for PCR detection of pathogens.

Alstroemeria mosaic virus (AlMV) is a (+) sense ssRNA virus of the genus Photivirus. The symptoms of AlMV infection vary greatly depending on the virus strain, infected Alstroemeria cultivar, and environmental factors. A typical AlMV infection symptom is leaf and flower crumbling with long yellow-green or dark spots along the veins.

On the other hand, Korea Patent No. 1322323 discloses 'a novel Mosquito mosaic virus found in plants of the genus White rice, a primer for its detection, and a method for detecting the Mosquito mosaic virus using the same', and in Korea Patent No. 2096633, Although 'a primer set for specifically detecting the quarantine plant virus, banana bract mosaic virus and its use' is disclosed, the primer set and its use for specifically detecting the Alstroemeria mosaic virus of the present invention are described. nothing has been described In addition, even if a PCR test method for the virus has been developed, since nucleotide sequence mutations occur continuously due to the characteristics of the virus, there is a need to upgrade to a PCR test method that can encompass such mutated sequences.

The present invention has been derived from the above needs, and the present inventors have developed a nucleic acid of AlMV from a known database to develop a primer set capable of specifically detecting Alstroemeria mosaic virus (AlMV). After collecting information and designing a candidate primer set, 18 candidate primer sets showing a specific reaction with the target virus gene were first selected. Six candidate primer sets were secondarily selected, and five candidate primers were finally selected through the non-specific reaction of the second-selected primer sets to plant genes. In addition, as a result of analyzing the sensitivity to the finally selected primer set, the present invention was completed by confirming that ^{the primer sets according to the present invention can detect up to an RNA concentration of 10 -2} to 10 ^{-3 ng.}

In order to solve the above problems, the present invention provides an oligonucleotide primer set of SEQ ID NOs: 1 and 11; oligonucleotide primer sets of SEQ ID NOs: 3 and 13; oligonucleotide primer sets of SEQ ID NOs: 3 and 14; oligonucleotide primer sets of SEQ ID NOs: 4 and 14; And it provides a primer set composition for specifically detecting Alstroemeria mosaic virus comprising one or more oligonucleotide primer sets selected from the group consisting of oligonucleotide primer sets of SEQ ID NOs: 7 and 18. .

In addition, the present invention is the oligonucleotide primer set; And it provides a kit for specifically detecting Alstroemeria mosaic virus, comprising a reagent for performing an amplification reaction.

In addition, the present invention isolates total RNA from a plant sample; amplifying a target sequence by using the isolated total RNA as a template and performing RT-PCR using the oligonucleotide primer set according to the present invention; And it provides a method for specifically detecting Alstroemeria mosaic virus, comprising the step of detecting the amplification product.

The five primer sets capable of specifically detecting Alstroemeria mosaic virus (AlMV) according to the present invention can detect AlMV easily and quickly, and thus can effectively prevent the introduction of AlMV into the country. It is presumed that there will be

1 shows the AlMV sequence alignment results and the positions of candidate primers for AlMV detection.
2 and 3 are results of verification of candidate primer sets using AlMV positive and negative samples.
4 to 6 are results of verification of candidate primer sets using four types of related viruses.
7 is a verification result of a candidate primer set using an AlMV test target sample.
8 is a result of analysis of the detection limit of a candidate primer set through an endpoint test.
9 shows the positions of the finally selected primer sets in the nucleotide sequence of the positive control clone prepared for the PCR test.
10 is a PCR reaction result of a clone containing a nucleotide sequence of a positive control prepared for PCR test.

In order to achieve the object of the present invention, the present invention provides an oligonucleotide primer set of SEQ ID NOs: 1 and 11; oligonucleotide primer sets of SEQ ID NOs: 3 and 13; oligonucleotide primer sets of SEQ ID NOs: 3 and 14; oligonucleotide primer sets of SEQ ID NOs: 4 and 14; And it provides a primer set composition for specifically detecting Alstroemeria mosaic virus comprising one or more oligonucleotide primer sets selected from the group consisting of oligonucleotide primer sets of SEQ ID NOs: 7 and 18. .

The primer set of the present invention preferably includes one or more, two or more, three or more, four or more primer sets selected from the group consisting of the five primer sets, and preferably all five primer sets. may include

The primers are 16 or more, 17 or more, 18 or more, 19 or more, 20 or more in the sequence of SEQ ID NOs: 1, 3, 4, 7, 11, 13, 14, and 18, depending on the sequence length of each primer. It may include an oligonucleotide consisting of fragments of more than one contiguous nucleotide. For example, the primer of SEQ ID NO: 1 (22 oligonucleotides) is a fragment of 16 or more, 17 or more, 18 or more, 19 or more, 20 or more, 21 or more consecutive nucleotides in the sequence of SEQ ID NO: 1 It may comprise an oligonucleotide consisting of In addition, the primer may also include an addition, deletion or substitution of the nucleotide sequences of SEQ ID NOs: 1, 3, 4, 7, 11, 13, 14, and 18.

The oligonucleotide primers of SEQ ID NOs: 1, 3, 4 and 7 of the present invention are forward primers, and the oligonucleotide primers of SEQ ID NOs: 11, 13, 14 and 18 are reverse primers.

In the present invention, "primer" refers to a single-stranded oligonucleotide sequence complementary to a nucleic acid strand to be copied, and can serve as a starting point for synthesis of a primer extension product. The length and sequence of the primers should allow synthesis of the extension product to begin. The specific length and sequence of the primer will depend on the conditions of use of the primer, such as temperature and ionic strength, as well as the complexity of the DNA or RNA target required.

As used herein, the oligonucleotide used as a primer may also contain a nucleotide analogue, for example, a phosphorothioate, an alkylphosphorothioate or a peptide nucleic acid or An intercalating agent may be included.

The present invention also provides the oligonucleotide primer set; And it provides a kit for specifically detecting Alstroemeria mosaic virus, comprising a reagent for performing an amplification reaction.

In one embodiment of the present invention, the reagent for performing the amplification reaction may include DNA polymerase, dNTPs, and a buffer, and may further include a ribonuclease inhibitor, a thermostable polymerase, and the like. However, it is not limited thereto. The DNA polymerase may be a reverse transcriptase such as an RNA dependent DNA polymerase, a reverse transcriptase from a variety of sources, for example, avian myeloblastosis virus-derived reverse transcriptase. derived virus reverse transcriptase (AMV RTase), murine leukemia virus-derived virus reverse transcriptase (MuLV RTase) and Rous-associated virus 2 reverse transcriptase (RAV-2 RTase) ), but is not limited thereto. In addition, the buffer may include both a reverse transcription buffer and a PCR buffer, and the heat-resistant polymerase may be EF Taq polymerase.

In addition, the kit of the present invention may further include a positive control sequence consisting of the nucleotide sequence of SEQ ID NO: 20. The nucleotide sequence of SEQ ID NO: 20 is a primer so that the five primer sets (total of eight oligonucleo primers) selected in the present invention can produce an amplification product having the same size as the expected amplification product size of each primer set without a non-specific reaction. As a nucleotide sequence artificially synthesized by adding a nucleotide sequence and an artificial nucleotide sequence (FIG. 9), it may be included in the kit in the form of a DNA fragment or a vector including the nucleotide sequence.

In one embodiment of the present invention, the kit may further include a user guide describing optimal conditions for performing the reaction. The handbook is a printout explaining how to use the kit, eg, how to prepare reverse transcription buffer and PCR buffer, and suggested reaction conditions. Instructions include a brochure in the form of a pamphlet or leaflet, a label affixed to the kit, and instructions on the surface of the package containing the kit. In addition, the guide includes information published or provided through electronic media such as the Internet.

The present invention also comprises the steps of isolating total RNA from plant samples; amplifying a target sequence by using the isolated total RNA as a template and performing RT-PCR using the oligonucleotide primer set according to the present invention; And it provides a method for specifically detecting Alstroemeria mosaic virus, comprising the step of detecting the amplification product.

The method of the present invention comprises the step of isolating total RNA from a plant sample. A method for isolating total RNA from the sample may use any method known in the art, for example, a phenol extraction method may be used. Using the isolated total RNA as a template and using one or more oligonucleotide primer sets according to an embodiment of the present invention as primers, RT-PCR (reverse transcription polymerase chain reaction) may be performed to amplify the target sequence. Such PCR methods are well known in the art, and commercially available kits may be used.

In the method according to an embodiment of the present invention, the plant is not limited to Alstroemeria, and any plant that can be infected with Alstroemeria mosaic virus may be included within the scope of the present invention.

In the method of the present invention, the amplified target sequence may be labeled with a detectable labeling substance. The labeling material may be a material emitting fluorescence, phosphorescence, or radioactivity, but is not limited thereto. Preferably, the labeling substance is Cy-5 or Cy-3. When PCR is performed by labeling Cy-5 or Cy-3 at the 5'-end of the primer during amplification of the target sequence, the target sequence may be labeled with a detectable fluorescent labeling material. ^{In addition, when a radioactive isotope such as 32} P or ³⁵ S is added to a PCR reaction solution for labeling using a radioactive material, the amplification product is synthesized and radioactivity is incorporated into the amplification product, so that the amplification product can be radioactively labeled. The one or more oligonucleotide primer combinations used to amplify the target sequence are as described above.

In one embodiment of the present invention, the method for detecting Alstroemeria mosaic virus includes detecting the amplification product, and the detection of the amplification product is a DNA chip, gel electrophoresis, capillary electrophoresis, radioactive Measurement, fluorescence measurement, or phosphorescence measurement may be performed, but is not limited thereto. As one of the methods for detecting the amplification product, capillary electrophoresis may be performed. Capillary electrophoresis may use, for example, an ABi Sequencer. In addition, gel electrophoresis can be performed, and agarose gel electrophoresis or acrylamide gel electrophoresis can be used for gel electrophoresis depending on the size of the amplification product. In addition, in the fluorescence measurement method, when PCR is performed by labeling the 5'-end of the primer with Cy-5 or Cy-3, the target sequence is labeled with a detectable fluorescent labeling material, and the labeled fluorescence is measured using a fluorometer. can do. In addition, the radioactive measurement method is a ^{radioactive isotope such as 32} P or ³⁵ S added to the PCR reaction solution during PCR to label the amplification product, and then a radioactive measuring instrument, for example, a Geiger counter or liquid scintillation. The radioactivity can be measured using a liquid scintillation counter.

Hereinafter, the present invention will be described in detail by way of Examples. However, the following examples are merely illustrative of the present invention, and the content of the present invention is not limited to the following examples.

Example 1. Primer set design for detecting Alstroemeria mosaic virus (AlMV)

Four AlMV sequences available in NCBI GenBank (as of May 2020) were sequence-aligned (FIG. 1), and candidate primers for AlMV-specific detection were designed based on the results (Table 1 and Table 2).

In order to verify the designed candidate primer set, it was necessary to test the specificity for the strain (target virus and related species) and to check whether non-specific products were generated for the test item. Related viruses to be used in the present invention are BBrMV (Banana bract mosaic virus), BCMV (Bean common mosaic virus), ChiVMV (Chilli veinal mottle virus) and TEV (Tobacco etch virus). All of the target virus and related viruses were purchased from Agdia Inc. (USA) and used. The plant to be inspected (seeds and plants; cultivated in greenhouses when plants are secured as seeds ) is Alstroemeria 'Appelbloesem'. The plants were used by purchasing seeds or seedlings judged to be virus-free.

Example 2. Verification of a primer set for detecting AlMV

PCR was performed to verify and select the candidate primer set designed in Example 1. Total RNA samples were extracted using the RNeasy plant mini kit (QIAgen, Germany). PCR was performed using RT-PCR Premix (PLUTOS, Korea; Company P), AccuPower RT-PCR PreMix & Master Mix (Bioneer, Korea; Company B), SuPrimeScript RT-PCR Premix (GeNet Bio, Korea; Company G) and the composition and reaction conditions of the mixture are shown in the table below.

2-1. Confirmation of AlMV species specificity

First, verification of candidate primers using AlMV positive and negative samples was performed.

As a result of verifying 26 candidate primer sets using AlMV-infected samples, primer set no. 18 except 1, 7, 15, 18, 19, 22, 24, 26 (no. 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 16, 17, 20, 21, 23, 25) was first selected ( FIGS. 2 and 3 ).

2-2. Validation of candidate primer sets using closely related viruses

As a result of confirming whether a non-specific reaction was performed against 4 types of closely related viruses using 18 primer sets selected primarily, the primer set no. Except for 2, 4, 5, 8, 9, 10, 13, 16, 17, 20, 21, 25, 6 (no. 3, 6, 11, 12, 14, 23) primer sets were selected (Fig. 4 to 6).

2-3. Validation of candidate primer sets using test target plants

As a result of confirming the non-specific reaction of the six primer sets on two types of test target plants using the secondly selected six primer sets, the primer set no. Except for 6, 5 (no. 3, 11, 12, 14, 23) primer sets were selected (FIG. 7).

2-4. Detection limit analysis of candidate primer sets through endpoint testing

In order to confirm the detection limit of the final selected five primer sets, sensitivity analysis was performed by varying the ^{total RNA template at concentrations of 10, 1, 10 -1} , 10 ^-2 , 10 ^-3 , 10 ^-4 , and 10 ^{-5 ng.} was performed. As a result, all the finally selected primer sets were able to detect up to an RNA concentration ^{of 10 -2} ng, and it was observed that the target band was confirmed even ^{at a template concentration of 10 -3 ng according to the PCR premix product (FIG. 8).} From the above results, it was confirmed that the primer set of the present invention was a marker with excellent sensitivity.

Example 3. Base sequence design and verification for producing positive control clones

The present inventors prepared a positive control clone that can be used as a positive control in the PCR test of the finally selected primer sets. The positive control clone is a primer so that the 5 primer sets (total of 8 oligonucleo primers) finally selected in the present invention can produce an amplification product having the same size as the expected amplification product size of each primer set without a non-specific reaction, respectively. It is a nucleotide sequence designed by adding a nucleotide sequence and an artificial nucleotide sequence (SEQ ID NO: 20, FIG. 9). The present inventors designed the base sequence of a positive control, and then prepared it in a cloned form into the pUCIDT-AMP vector (IDT, USA).

In order to confirm the efficiency of the prepared positive control clone, PCR was performed using ^{1 ng and 10 -1 ng of the positive control clone as a template.} The composition of the PCR mixture was the same as in Table 3 except for the N25 primer, and the reaction conditions were the same as in Table 4 except for the RT reaction. As a result, as shown in FIG. 10, it was found that all of the five primer sets finally selected in the present invention amplify the PCR product of the expected size, and the positive control clone prepared through this amplifies the PCR test of the present invention. It was found that it can effectively function as a positive control for the primer set.

<110> REPUBLIC OF KOREA (Animal and Plant Quarantine Agency) <120> Specific primer set for detecting Alstroemeria mosaic virus and uses it <130> PN20425 <160> 20 <170> KoPatentIn 3.0 <210> 1 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 1 ggatgttgac aggatttgca ag 22 <210> 2 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 2 ggacatcctt gacagactgg 20 <210> 3 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 gatttctcct cacgaaccag 20 <210> 4 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 caatcttaca gtgggatcgc 20 <210> 5 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 accgtcttga ggcaatctgt 20 <210> 6 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 gtgtgaagat ttcgaggtgc 20 <210> 7 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 7 agcaaggaca aacaggtagc 20 <210> 8 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 8 gatgtcaatg caggcacttc 20 <210> 9 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 9 gctacctgtt tgtccttgct 20 <210> 10 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 10 gaagtgcctg cattgacatc 20 <210> 11 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 11 tcctgtgatg gctttgatgc 20 <210> 12 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 12 gtggtagatt cagtgcatcc 20 <210> 13 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 13 cgtgccatgc attgaattgc 20 <210> 14 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 14 tcgatgcacc acaccattag 20 <210> 15 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 15 cttgttgttc gccatccatc 20 <210> 16 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 16 tacgcctctg caacatccga 20 <210> 17 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 17 aggctcgcat ctcgtaagtt 20 <210> 18 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 18 tcggagtacg agatgtgacc 20 <210> 19 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 19 ccgaacattc gagtttgcac 20 <210> 20 <211> 1169 <212> DNA <213> Artificial Sequence <220> <223> positive control sequence <400> 20 gagaagcatg accgggaaat ccacgaacca cccgttgata tcacggccca tccgagcagg 60 cgattccaca agaatcgtgt tgagcgacca ctcgcagaaa atgtacactc aacgtagagc 120 tgcagcacat tccttaagga agcactcgtc tcgagcataa tgcgactatc tggaatttcc 180 cttggagctg agaccagatg gaacccttaa tagcctcgcc tatgaagtct ccaaaattgc 240 gtgcgcacct gtcaaacacg caatggccct gacggttatg tcggatggga tgttggtaga 300 tcagctcacg agagcttcac attgactcct gaggcaaatc aaacgggaat aagcaaggac 360 aaacaggtag cgcccggtaa cattgccgaa gatttctcct cacgaaccag atcccttaac 420 ggatgttgac aggatttgca agacctagtt gatgcgcagg gtacaggtgc caaatcgtct 480 gacagtctac acttccaagc aatcttacag tgggatcgcg aattgcagtt cccgattgta 540 gcgaaacctt aagatggacc gaagaatctt agttaccatt cctgcattcg aagcaaatgc 600 tcctgggacg tgcctattgg ctaaactacg cgaggatata gcttggcact ccaactggac 660 acccagggag ctgtgaatgg atccaatggg actgttatcc gaggacagtg gccaacgatg 720 acaatcattg ccactggagg cgaatgacca tactggtcag aagtcccgca gagcataatg 780 cgactatctg gtttaacgcc atgatctcga ggaggcaagc actttagtcg gatttgaaag 840 gaccactgaa ctcctcgacg ctaatcacta tggtactcgt catctactga cttctcagtc 900 aactgatttc cagacgctaa ggtcacatct cgtactccga ttcgaaccta gcaataccgc 960 atttggcaat ccgcttatac ttaactggga gttgtggtca gacaatgcca gatgacaggc 1020 attagccgtt gatcatggcc attcaaatct cggatcgtaa gcgcctatgg gcaattcaat 1080 gcatggcacg aatacatgca tcaaagccat cacaggataa tgcctcgata aatcggatca 1140 cgttaaagtc taatggtgtg gtgcatcga 1169

Claims (6)

oligonucleotide primer sets of SEQ ID NOs: 1 and 11; oligonucleotide primer sets of SEQ ID NOs: 3 and 13; oligonucleotide primer sets of SEQ ID NOs: 3 and 14; oligonucleotide primer sets of SEQ ID NOs: 4 and 14; And a primer set composition for specifically detecting Alstroemeria mosaic virus comprising the oligonucleotide primer sets of SEQ ID NOs: 7 and 18. The oligonucleotide primer set according to claim 1; And a kit for specifically detecting Alstroemeria mosaic virus, comprising a reagent for performing an amplification reaction. The kit according to claim 2, wherein the reagents for performing the amplification reaction include DNA polymerase, dNTPs and a buffer. The kit according to claim 2, wherein the kit further comprises a positive control sequence consisting of the nucleotide sequence of SEQ ID NO: 20. isolating total RNA from a plant sample;
using the isolated total RNA as a template and amplifying a target sequence by performing RT-PCR using the oligonucleotide primer set according to claim 1; and
A method for specifically detecting Alstroemeria mosaic virus, comprising the step of detecting the amplification product. The method according to claim 5, wherein the detection of the amplification product is performed through a DNA chip, gel electrophoresis, radiometric measurement, fluorescence measurement, or phosphorescence measurement.

Images